H.P. Acthar Gel
H.P. Acthar Gel is a pharmaceutical drug with 10 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
2
Mid Stage
6
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
83.3%
5 of 6 finished
16.7%
1 ended early
0
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Treatment of CNS Sarcoidosis With H.P. Acthar Gel
Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis
Efficacy and Safety of H.P. ACTHAR GEL in Adults With Retinal Vasculitis
A Two-Arm Study Evaluation H.P. Acthar Injection Gel in Treatment of Chronic Migraines
(ACTH) for the Treatment of Sarcoid Uveitis
Clinical Trials (10)
Treatment of CNS Sarcoidosis With H.P. Acthar Gel
Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis
Efficacy and Safety of H.P. ACTHAR GEL in Adults With Retinal Vasculitis
A Two-Arm Study Evaluation H.P. Acthar Injection Gel in Treatment of Chronic Migraines
(ACTH) for the Treatment of Sarcoid Uveitis
Efficacy, Radiographic and Laboratory Changes in Refractory Rheumatoid Arthritis Patients Treated With H.P. Acthar Gel
Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating Neuropathy
Addition of H.P. Acthar Gel to Treatment Regimen of Patients With Rheumatoid Arthritis
Idiopathic Focal Segmental Glomerulosclerosis (FSGS) and Treatment With ACTH
Open-label Trial of Acthar Gel in Subjects With Moderate to Severe Active Systemic Lupus Erythematosus
All 10 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 10